Abstract 372: VGF is functionally responsible for chemotherapy resistance in non-small cell lung cancer

Abstract Despite the success of immune checkpoint therapy, most non-small cell lung cancer (NSCLC) patients still receive conventional chemotherapy. Overcoming chemotherapy resistance by identifying specific targets should improve cancer treatment and patient survival. In this study, we examined a p...

Full description

Saved in:
Bibliographic Details
Published inCancer research (Chicago, Ill.) Vol. 79; no. 13_Supplement; p. 372
Main Authors Nogami, Wataru, Tona, Yumi, Tofukuji, Soichi, Ishioka, Yoshino, Matsumoto, Mitsunobu, Yamada, Hajime, Kuwabara, Kenji, Tanaka, Hidekazu, Adachi, Shigeki, Yamamoto, Yoko, Kanzaki, Ryu, Funaki, Soichiro, Shintani, Yasushi, Okumura, Meinoshin, Nomura, Taisei
Format Journal Article
LanguageEnglish
Published 01.07.2019
Online AccessGet full text

Cover

Loading…